Companies Reporting Before The Bell
• AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion.
Over the past three months, shares of Genpact Inc. (NYSE:G) decreased by 2.68%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.
Joint Center of Excellence and Ongoing Mutual Technology Investments to Enhance Clients' Digital Transformation
NEW YORK, Nov. 9, 2022 /PRNewswire/ -- Genpact (NYSE:G), a global professional services
Genpact (NYSE:G) has outperformed the market over the past 15 years by 1.26% on an annualized basis producing an average annual return of 7.32%. Currently, Genpact has a market capitalization of $8.34 billion.
Genpact (NYSE:G) has outperformed the market over the past 15 years by 1.2% on an annualized basis producing an average annual return of 8.18%. Currently, Genpact has a market capitalization of $8.70 billion.